Log In
Print this Print this

Bosulif, bosutinib (PF-05208763, PF-5208763, SKI-606)

  Manage Alerts
Collapse Summary General Information
Company Pfizer Inc.
DescriptionDual inhibitor of BCR-ABL and Src kinase
Molecular Target BCR-ABL tyrosine kinase ; Src
Mechanism of Action 
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today